203 related articles for article (PubMed ID: 36142786)
1. Intercontinental Gut Microbiome Variances in IBD.
Mayorga L; Serrano-Gómez G; Xie Z; Borruel N; Manichanh C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142786
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.
Kang DY; Park JL; Yeo MK; Kang SB; Kim JM; Kim JS; Kim SY
BMC Microbiol; 2023 Nov; 23(1):336. PubMed ID: 37951857
[TBL] [Abstract][Full Text] [Related]
3. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
4. Overrepresentation of Enterobacteriaceae and
Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
[TBL] [Abstract][Full Text] [Related]
5. A microbial signature for Crohn's disease.
Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
[TBL] [Abstract][Full Text] [Related]
7. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
[TBL] [Abstract][Full Text] [Related]
8. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.
Ungaro F; Massimino L; Furfaro F; Rimoldi V; Peyrin-Biroulet L; D'Alessio S; Danese S
Gut Microbes; 2019; 10(2):149-158. PubMed ID: 30252582
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
11. Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
Boland K; Bedrani L; Turpin W; Kabakchiev B; Stempak J; Borowski K; Nguyen G; Steinhart AH; Smith MI; Croitoru K; Silverberg MS
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):296-304.e3. PubMed ID: 32220613
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota signatures in inflammatory bowel disease.
Vestergaard MV; Allin KH; Eriksen C; Zakerska-Banaszak O; Arasaradnam RP; Alam MT; Kristiansen K; Brix S; Jess T
United European Gastroenterol J; 2024 Feb; 12(1):22-33. PubMed ID: 38041519
[TBL] [Abstract][Full Text] [Related]
13. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
14. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean.
Rausch P; Ellul S; Pisani A; Bang C; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Inflamm Bowel Dis; 2023 Jul; 29(7):1118-1132. PubMed ID: 36735955
[TBL] [Abstract][Full Text] [Related]
15. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.
Park Y; Ahn JB; Kim DH; Park IS; Son M; Kim JH; Ma HW; Kim SW; Cheon JH
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928402
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods.
Bakir-Gungor B; Hacılar H; Jabeer A; Nalbantoglu OU; Aran O; Yousef M
PeerJ; 2022; 10():e13205. PubMed ID: 35497193
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character).
Vatn S; Carstens A; Kristoffersen AB; Bergemalm D; Casén C; Moen AEF; Tannaes TM; Lindstrøm J; Detlie TE; Olbjørn C; Lindquist CM; Söderholm JD; Gomollón F; Kalla R; Satsangi J; Vatn MH; Jahnsen J; Halfvarson J; Ricanek P;
Scand J Gastroenterol; 2020 Oct; 55(10):1146-1156. PubMed ID: 32780604
[TBL] [Abstract][Full Text] [Related]
20. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
